Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 342

Liki24 raises USD5m from Horizon Capital and existing investors

Submitted 14/08/2020 - 9:17am

Liki24, a Ukraine-based e-commerce platform for medicine delivery, has raised a USD5 million round from Horizon Capital and existing investors, bringing total funding raised to date to USD6 million. 

This new equity round will support the Company’s ambitious European expansion plans, with Poland being the first international market where Liki24 launched operations last month.

Liki24.com is a marketplace aggregating offers from thousands of pharmacies and facilitating transactions between pharmacies and consumers. Liki24 launched in Ukraine in late 2017, addressing three consumer pain points: significant variation in pricing among market players, limited availability of medicines in one point of sale, and lack of home delivery. In less than three years since inception, the Company has connected 5,000-plus pharmacies and completed over 500,000 orders powered by a proprietary software system that integrates with pharmacies’ ERPs, instantly analysing prices and availability of medicines, developing optimal routes for couriers, thus allowing for rapid delivery to customers at affordable prices. 

Liki24 played a crucial role during the coronavirus lockdown in Ukraine to ensure people sheltering at home had access to lifesaving medication. The Company partnered with local logistics operators to offer free delivery of medication during the quarantine. Recently, Liki24 was named by Sifted among the few European start-ups helping to ease the negative impact of coronavirus, with BBC featuring the Company among services that help patients during lockdown.

Liki24 was launched by Anton Avrinsky, the CEO and founder, with a vision to introduce innovation and convenience to the pharmacy retail industry. Anton and Liki24’s core team members demonstrate solid technology and business development experience, having worked together for over 10 years at a leading Eastern European IT company. 

"Our business model proved to be successful in Ukraine, helping customers access more affordable medicines and convenient delivery," says Anton Avrinsky, CEO and founder of Liki24. "This capital raise will enable us to expand our team as well as extend our winning model to the Polish market and finance further international expansion at a time when safe and rapid delivery of medication is critical to the wellbeing of society. Our mission is to help our clients source medicines and receive them faster, at cheaper prices, and with greater convenience. 

"Furthermore, pharmacies benefit from new revenue streams, allowing them to capitalise more readily on additional e-commerce sales. Liki24 is a tech-driven company, bringing the latest technologies to the traditional pharma retail industry. The substantial size of the market and untapped potential creates tremendous opportunities for Liki24. We look forward to investing funds, time and effort to ensure consumers enjoy the benefits of our innovation as quickly as possible. We are thrilled to launch our global expansion with our entry to Poland this past month."

Lenna Koszarny, Founding Partner and CEO at Horizon Capital, says: “Horizon Capital is delighted to partner with Liki24 talented founders and join the Company’s impressive existing investor base. We look forward to contributing to the Company’s continued growth in the years ahead. Liki24 has an attractive mix of elements crucial for success, including strong founders with a bold vision, drive and demonstrated execution-ability, backed by a highly professional management team. Our investment in Lik24 is consistent with our focus on visionary founders with a clear expansion strategy who seek out a partnership with Horizon Capital to reach new heights."

Tags Deals & Transactions Investments

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.